One Stop Shop for All Your Market Research Reports

Global Market Study on Compounding Pharmacies: Regulatory Harmonization and Innovative Therapeutic Areas to Boost Demand for Compounded Drugs

Compounding Pharmacies are pharmacies that produce drugs tailored to needs of individual patients, by altering, combining, or mixing active pharmaceutical ingredients of drugs. Compounded drugs are prepared under prescription from physicians. Compounding includes the combination of two or more drug ingredients in varied proportions. Most regulatory agencies across the world do not approve compounded medications and do not verify the safety or effectiveness of compounded drugs. These drugs are mostly not reimbursed by pharmaceutical benefits agencies. The global compounding pharmacies market report deals with compounded drugs, which are customized medicines, prepared by a pharmacist, or a physician and are available in strengths not commercially available. These medicines are easily available at community pharmacies and are known to provide personalized relief. Compounded drugs are available in various forms such as oral applications (capsules, mixtures, etc.), topical applications (creams, gels, lotions, ointments, etc.), and suppositories. These drugs can be formulated for both human beings and animals. The global compounded drug market is expected to expand at a CAGR of 6% over the forecast period (2015?2021) to account for US$ 9,751 Mn by 2021.
Inquiry Before Buying
Request Sample
To choose the report type and your desired payment method

Share This Report

Our Clients

Latest Market News

Sinochem and ChemChina Merger Talks – Deal by End of Year

The state-owned Sinochem and ChemChina merger talks are currently taking place.  A merger between the two Chinese firms would create the largest industrial chemicals company in the world. It is believed that the merged company would be run by Ning Gaoning, the head of state-owned Sinochem.   ChemChina (prop [...]

Read More
Falling Oil Prices Aggravated by US Oil Stockpile Sell-off

Falling oil prices Tuesday. Oil prices fell Tuesday on the back of a plan by US President Donald Trump. The White House announced a plan to sell off half of America’s oil reserves. This would create a glut on the market at a time when OPEC members and allies are cutting production in order to maintain prices. &nbs [...]

Read More
US Climate Change Issues – Investors to Manage Global Warming Risk

US climate change issues are forcing investors to go it alone in the absence of action by President Trump.  This is largely because shareholders in large energy companies are pressing them to take action on rising global temperatures.  They fear that an increase in environmental temperature could have an effect on th [...]

Read More
RBS Court Case – Royal Bank of Scotland Bailout Case Adjourned

The RBS court case has been adjourned.  The Royal Bank of Scotland bailout by the UK government has prevented its collapse. Investors are claiming that they were misled about the financial situation of the bank when they were asked to invest to help purchase the rival Dutch bank, AMV Avro, in 2007.   This d [...]

Read More
US and Saudi Arabia Business Deals: Saudi – US Meeting a Success

The US and Saudi Arabia business deals we reported yesterday have been signed. The deals were finalized during President Trump's visit to the Middle Eastern kingdom. US - Saudi Aramco deals amounted to $50 billion of the $200 billion overall total. The Saudi - US meeting was generally regarded as a success. [...]

Read More
Payment Mode
Single User $ 4900
Multi User $7600
Corporate User $10600
About this Report
Report ID 13007
Category
  • Biotechnology
Published on 12-Oct
Number of Pages 160
Publisher Name Persistence Market Research
Over all Rating
"Rating is based on 14 reviews"